🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Delighted to present our exciting Ph1 data ‘FIRST IN HUMAN STUDY OF AUTO4, TRBC1‐TARGETING CART, IN R/R TRBC1+ve PTCL’ at #17ICML Credit to co-I: ⁦Gloria Iacoboni⁩ #MartinPule #EleniTholouli ⁦tobiasmenne⁩ #DavidIrvine ⁦Paul Maciocia⁩ onlinelibrary.wiley.com/doi/10.1002/ho…

So proud of our GW Cancer Center fellows, congratulations to Dr Estephan and Dr Guadeloupe. #graduation #hematology #oncology

Great discussion/overview on ins and outs of primary and secondary CNS lymphoma ⁦Kate Cwynarski⁩⁦International Conference on Malignant Lymphoma⁩

Such a privilege to be part of the JSH 2023 meeting. I was so impressed overall and particularly by the outstanding quality of the Japanese junior researchers’ presentations and science. Looking forward to great collaborations and returning some day. ⁦

🔎Gain insight into CAR T-cell therapies across #lymphoma and #multiplemyeloma. Watch the full coverage of our session at #EHA2023, chaired by Ulrich Jäger. The ins and outs of CAR T cells in the real world🌎 👇 loom.ly/BkyfO8Q #mmsm #lymsm #CART #CARTcells

Interesting data: in our MDT/w our patients we discuss: R-CHOP-14 vs R-DA-EPOCH? Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4068 patients #MichaelCook Kieron Dunleavy haematologica.org/article/view/h…

Mentor appreciation post! ASH’s new Visiting International Clinical Research Program connects fellows from around the globe with U.S.-based mentors for a virtual postdoctoral period of training. Ann LaCasce, MD, Kieron Dunleavy, Christopher Flowers, & Dr. Peter Martin 🌎🩸

Having a great time talkin’ lymphoma at our Roswell Park and Beyond Trauma Foundation #ASH23 review with Drs. Paolo F. Caimi, Kieron Dunleavy, Jeremy Abramson Jeremy Abramson, MD and Paco Francisco Hernandez with 🎯 questions from Pallawi Torka, Alex Niu et al!🧐 #Buffalo #niagarafalls #lymsm

This month, we’re celebrating the inspiring women at the American Cancer Society. Meet Dr. Christina Annunziata, Senior VP Extramural Discovery Science. She shares some advice for young women pursuing a STEM career path. Learn more about our researchers: amercancer.co/whmresearch

ALLG’s BrainCAR19 trial in relapsed Primary Central Nervous System Lymphoma (PCNSL) has received an MRFF grant to open in Australia. Led by Dr Keane, it’s the first Aus trial to use locally manufactured CAR-T cells along with targeted therapies. Visit allg.org.au.

🙌 Agree, esp. regarding the use of checkpoint inhibitor therapy during pregnancy (ncbi.nlm.nih.gov/pmc/articles/P…) 👉Though, Kieron, INCIP (International Network on Cancer, Infertility and Pregnancy) is a great cross-tumor, global collaborative doing just this: cancerinpregnancy.org

Lymphoma Classifications, How to Develop a Future Unified Taxonomy | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

It was an incredible night launching our first MidAntlantic Fellow Blood 🩸 Club bringing institutions and fellows together. Thank you for everyone for making this a reality and our moderators and speakers. Kieron Dunleavy, Dr Aarti shenoy and Dr J. Kanakri

Register today for the 2024 ASCO Direct Washington D.C. Conference, Sept. 14-15th. Join Georgetown Lombardi MedStar Georgetown faculty, including John Marshall, Dr. Claudine Isaacs, Geoff Gibney, Chul Kim, Kieron Dunleavy, and Dr. Nancy Dawson. Learn more: totalhealthoncology.com/upcoming-oncol…

Exciting news: the 1st episode of a new BBC News (UK) show counting down to the US election is about to start on the BBC News channel. In ‘Path To The Presidency’, I talk all things about the race to the @whitehouse with Katty Kay Sumi Somaskanda it is also a pod & on @youtube

Lymphoma Classifications, How to Develop a Future Unified Taxonomy WHO-HAEM5 & Int Consensus Classif (ICC) dev by Clinical Advisory Committee ‘these two lymphoma classifications have more commonalities than differences’ #EliasCampo et al Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

imt.ie/news/mater-ope… Mater opens Ireland’s first dedicated early phase cancer trials unit Mater Hospital Advanced Cancer Care Mater Hospital Foundation STARTDublin

Our Malignant Hematologic Oncology program brings together world-class specialists in all types of blood cancers, including yours. Our team has extensive knowledge and experience in caring for your particular disease. ms.spr.ly/6017oQnWc

The dark zone of CNS relapse in DLBCL ow.ly/VUKM50UVniO #clinicaltrialsandobservations

Drs. Kieron Dunleavy , Francisco Hernandez-Ilizaliturri and drjoannarhodes presenting key updates in the management of high-grade B-cell lymphomas post #ASH24 #lymsm Roswell Park OncLive.com